N. Imai

Induction of cellular immune responses to tumor cells and peptides in colorectal cancer patients by vaccination with SART3 peptides.

K. Shirouzu, H. Yamana, K. Itoh, 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

Phase 1 Clinical Study of Cyclophilin B Peptide Vaccine for Patients With Lung Cancer

H. Yamana, M. Kawamoto, K. Itoh, 2002, Journal of immunotherapy.

Immunological evaluation of CTL precursor‐oriented vaccines for advanced lung cancer patients

K. Shirouzu, H. Yamana, H. Aizawa, 2003, Cancer science.

Non-mutated tumor-rejection antigen peptides elicit type-I allergy in the majority of healthy individuals.

T. Nukiwa, S. Shichijo, K. Itoh, 2002, Tissue antigens.

Elevation of Serum MAGE‐4 Protein Levels and Prediction of Hepatocellular Carcinogenesis in Patients with Liver Cirrhosis

M. Sata, S. Shichijo, K. Itoh, 2002, Japanese journal of cancer research : Gann.

Serine Proteinase Inhibitor 9 Can Be Recognized by Cytotoxic T Lymphocytes of Epithelial Cancer Patients

Koji Tanaka, S. Shichijo, F. Niiya, 2002, Japanese journal of cancer research : Gann.

Identification of Lck‐derived peptides capable of inducing HLA‐A2‐restricted and tumor‐specific CTLs in cancer patients with distant metastases

K. Itoh, A. Yamada, N. Harashima, 2001, International journal of cancer.

Cleavage and polyadenylation specificity factor (CPSF)‐derived peptides can induce HLA‐A2‐restricted and tumor‐specific CTLs in the majority of gastrointestinal cancer patients

S. Todo, Masaaki Ito, S. Shichijo, 2002, International journal of cancer.